Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Product Launch

18 Nov 2005 07:00

Original Investments PLC18 November 2005 Original Investments PLC ("Original Investments" or "the Company") Commercial product launch from Acrobot Visualisation software, enabling orthopaedic surgeons to producethree-dimensional bone surface models from Computed Tomography (CT) scans forpre-operative surgical planning, is launched today by The Acrobot Company("Acrobot"). Acrobot is a spin-out company from Imperial Innovations, the technologycommercialization company of Imperial College, London, and develops surgicalsystems for minimally-invasive, bone-conserving orthopaedic surgery. TheAIM-quoted company Original Investments (formerly BioProjects International)owns 25% of Acrobot's equity. The new software, called the Acrobot(R) Planner, is Acrobot's first commercialproduct and is being provided free of charge to surgeons who register to use it.Acrobot will receive fees for data preparation and bone modeling. The Acrobot(R) Planner gives the user the ability to visualise a patient's threedimensional bone surface models built from CT scans. The visualisation isinteractive and the user can select and position implant models onto the bones,evaluate the resulting range of motion, and produce reports. "The software will enable surgeons to assess accurately the exact requirementfor each operation and precisely plan the procedure beforehand," says Dr. PaulaGomes, Acrobot's Director of Operations. "It will help to reduce surgicalerrors, surgeon's stress, and overall procedure costs and times. Radiologistswill also use the software to produce enhanced reports." Further uses for the software will be as a powerful tool for teaching and alsogenerating visual material for presentations. Acrobot provides a commercial service for Acrobot(R) Planner users by taking theraw CT DICOM data, segmenting them and building bone surface models from theinformation. The user can import these patient-specific models into thesoftware, and perform hip resurfacing pre-operative surgical planning and/ orimpingement analysis. The data processing service removes the need for the userto be involved in time-consuming routine data preparation tasks. The Acrobot(R) Planner has been developed by the Acrobot team at the company'slaboratories in London's Leathermarket. It is the first of a number of relatedproducts to be produced by Acrobot, which was founded six years ago by ImperialInnovations as a collaboration to combine the skills of clinicians andacademics. Acrobot is initially focusing on developing precision surgical systems forminimally-invasive techniques in knee and hip replacement. With each product theoverall aims are to reduce error, increase accuracy and enable more difficultsculpted surfaces to be achieved for the new generation of 'resurfacing' orpartial joint implants. Products planned for launch in 2006 include the Acrobot(R) Navigation System,which provides visual guidance for the surgeon and is now undergoing regulatoryapproval, and the Acrobot Hands-On Robotic System, which has already beensuccessfully proven in clinic for unicompartmental knee arthroplasty. "We are delighted that our faith in Acrobot is beginning to bear commercialfruit," said Terry Bond, managing director of Original Investments. "Four yearsago we were the first investors outside Imperial College to provide seed-cornfunding for the company and we have continued to support it through the variousstages of its development." Further information on Original Investments PLC from Terry Bond, ManagingDirector, 01235 834734. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Apr 201412:30 pmRNSSuspension
9th Apr 20141:55 pmRNSChange of Advisers and Registered Office
26th Mar 20143:16 pmRNSCompletion of VEC Transfer
21st Mar 20147:00 amRNSResignation of Dr. Robert Dean
19th Mar 20143:09 pmRNSReplacement announcement: Grant of options
19th Mar 201412:25 pmRNSGrant of options
7th Mar 20141:43 pmRNSHolding(s) in Company
7th Mar 20141:39 pmRNSHolding(s) in Company
27th Jan 20142:00 pmRNSResult of General Meeting
24th Jan 20143:22 pmRNSResult of Open Offer
7th Jan 20147:00 amRNSPlacing, Open Offer & Notice of General Meeting
4th Dec 20134:13 pmRNSResult of General Meeting
2nd Dec 20138:00 amRNSHalf Yearly Report
18th Nov 20131:30 pmRNSNotice of General Meeting & Proposed Board Changes
29th Oct 20133:31 pmRNSResult of AGM
29th Oct 20137:00 amRNSRestructure Proposals
30th Sep 20137:00 amRNSFinal Results
29th Aug 20139:00 amRNSNotice of AGM
19th Jun 20133:09 pmRNSExercise of Warrants & TVR
8th May 20137:00 amRNSContract Win
29th Apr 20137:00 amRNSBusiness & Technical Collaboration with CGG
16th Apr 20137:00 amRNSChange of Adviser
12th Apr 20137:00 amRNSChevron - precision subsurface mapping contract
8th Feb 20133:01 pmRNSPlacing of £1.4 million
7th Jan 20137:00 amRNSFiling of QuantumRD patents in nine countries
2nd Jan 20138:36 amRNSChevron Expands ViaLogy Contract
31st Dec 20127:00 amRNSHalf Yearly Report
19th Dec 20127:00 amRNSCEO Overview
21st Nov 20127:00 amRNSMove into Shale Oil Development
16th Nov 20127:00 amRNSNorth Sea Project Underway
1st Oct 20127:00 amRNSQuantumRD Services in China
20th Sep 20127:00 amRNSPresentation at Singapore Conference
23rd Jul 20121:50 pmRNSResult of AGM
29th Jun 20127:00 amRNSFinal Results
15th Jun 201211:25 amRNSResult of General Meeting
23rd May 20127:00 amRNSNotice of General Meeting
21st May 20127:00 amRNSPlacing
11th May 20129:30 amRNSIssue of Equity - Options Exercise
10th May 20127:00 amRNSBusiness Update
2nd May 201212:24 pmRNSContract Award
23rd Apr 20127:00 amRNSContract win
16th Apr 20127:00 amRNSSuccessful Texas Oil Well Drilled
12th Apr 20127:00 amRNSContract Win
14th Mar 20127:00 amRNSQuantumRD demonstration to Chevron
18th Jan 20127:00 amRNSPlacing and TVR
3rd Jan 20127:00 amRNSBusiness Update
30th Dec 20117:00 amRNSInterim Report & Accounts
28th Oct 201112:36 pmRNSResult of AGM
11th Oct 20113:28 pmRNSPlacing & TVR
30th Sep 20117:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.